RCM Technologies, Inc.

As of October 17, 2025, RCM Technologies, Inc. is considered undervalued with a P/E ratio of 24 and strong fundamentals, despite a recent decline in stock performance, indicating a favorable long-term outlook.

As of September 2, 2025, RCM Technologies, Inc. shows a mildly bullish trend with positive MACD and Bollinger Bands, despite mixed signals from KST and OBV, and has outperformed the S&P 500 with a year-to-date return of 24.05%.

As of July 7, 2025, RCM Technologies, Inc. is considered attractively valued with a P/E ratio of 24, strong profitability metrics (ROCE of 40.59% and ROE of 37.45%), and a year-to-date stock return of 24.05%, significantly outperforming the S&P 500.

As of June 20, 2025, the trend is mildly bullish due to positive signals from the MACD and Bollinger Bands, but mixed indicators like the monthly MACD and bearish weekly RSI suggest caution.

As of November 7, 2024, RCM Technologies, Inc. is fairly valued with a P/E ratio of 24 and an EV to EBITDA of 13.80, showing strong performance with an 18.25% return over the past year, despite a downgrade in valuation grade from very attractive to attractive compared to peers like Barrett Business Services and Heidrick & Struggles.

As of March 2022, the management team of RCM Technologies, Inc. includes Mr. Bradley Vizi as Executive Chairman and President, Mr. Roger Ballou as Lead Independent Director, and Independent Directors Mr. Richard Genovese and Ms. Swarna Srinivas Kakodkar.

RCM Technologies, Inc. provides business and technology solutions in engineering, health care, and information technology services. As of March 2025, it reported net sales of $84 million and a net profit of $4 million, with a market cap of $303.88 million.

As of Jun 18, RCM Technologies, Inc. has a market capitalization of 303.88 million and net sales of 290.91 million with a net profit of 13.57 million over the latest four quarters.